Proceedings of the 2022 Cannabis Clinical Outcomes Research Conference.

Nicole E Smolinski, Ruba Sajdeya, Robert Cook, Yan Wang, Almut G Winterstein, Amie Goodin
Author Information
  1. Nicole E Smolinski: Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, Florida, USA.
  2. Ruba Sajdeya: Consortium for Medical Marijuana Clinical Outcomes Research, University of Florida, Gainesville, Florida, USA.
  3. Robert Cook: Consortium for Medical Marijuana Clinical Outcomes Research, University of Florida, Gainesville, Florida, USA.
  4. Yan Wang: Consortium for Medical Marijuana Clinical Outcomes Research, University of Florida, Gainesville, Florida, USA.
  5. Almut G Winterstein: Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, Florida, USA.
  6. Amie Goodin: Pharmaceutical Outcomes and Policy, University of Florida, Gainesville, Florida, USA.

Abstract

The Consortium for Medical Marijuana Clinical Outcomes Research, a multi-university collaboration established by the state of Florida in the USA, hosted its second annual Cannabis Clinical Outcomes Research Conference (CCORC) in May 2022. CCORC was held as a hybrid conference, with a scientific program consisting of in-person and virtual sessions. CCORC fostered and disseminated current research on clinical outcomes of medical marijuana while stimulating collaboration and engagement between the scientific community, policymakers, industry representatives, clinicians, and other interested stakeholders. Three themes emerged from conference sessions and speakers: (1) disentangling research findings comparing use and outcomes of medical and nonmedical cannabis, (2) addressing barriers and promoting facilitators for clinical cannabis research, and (3) resolving uncertainties around cannabis dosing. The third annual CCORC is planned for the summer of 2023 in Florida, USA.

Keywords

References

  1. Addiction. 2020 Jul;115(7):1207-1216 [PMID: 31606008]
  2. J Prim Care Community Health. 2021 Jan-Dec;12:21501327211042790 [PMID: 34452585]
  3. Med Cannabis Cannabinoids. 2021 Jun 17;4(2):121-124 [PMID: 35224432]
  4. Med Cannabis Cannabinoids. 2021 Sep 10;4(2):143-146 [PMID: 35224433]

Word Cloud

Created with Highcharts 10.0.0CannabisCCORCresearchclinicaloutcomesMarijuanaClinicalOutcomesResearchConferenceconferencecannabisMedicalcollaborationFloridaUSAannual2022scientificsessionsmedicalmarijuanaConsortiummulti-universityestablishedstatehostedsecondMayheldhybridprogramconsistingin-personvirtualfostereddisseminatedcurrentstimulatingengagementcommunitypolicymakersindustryrepresentativescliniciansinterestedstakeholdersThreethemesemergedspeakers:1disentanglingfindingscomparingusenonmedical2addressingbarrierspromotingfacilitators3resolvinguncertaintiesarounddosingthirdplannedsummer2023ProceedingsCannabidiolCannabinoidsproceedingsefficacy

Similar Articles

Cited By (2)